TGF-j3 signaling in health and disease

被引:223
|
作者
Massague, Joan [1 ]
Sheppard, Dean [2 ,3 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10065 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA
[3] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA
关键词
GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEIN; OF-FUNCTION MUTATIONS; DEPENDENT KINASE INHIBITOR; BREAST-CANCER METASTASIS; ANTI-MULLERIAN HORMONE; REGULATORY T-CELLS; GENOMIC CHARACTERIZATION; ACROMESOMELIC DYSPLASIA; TARGETED DISRUPTION;
D O I
10.1016/j.cell.2023.07.036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The TGF-j3 regulatory system plays crucial roles in the preservation of organismal integrity. TGF-j3 signaling controls metazoan embryo development, tissue homeostasis, and injury repair through coordinated effects on cell proliferation, phenotypic plasticity, migration, metabolic adaptation, and immune surveillance of multiple cell types in shared ecosystems. Defects of TGF-j3 signaling, particularly in epithelial cells, tissue fibro-blasts, and immune cells, disrupt immune tolerance, promote inflammation, underlie the pathogenesis of fibrosis and cancer, and contribute to the resistance of these diseases to treatment. Here, we review how TGF-j3 coordinates multicellular response programs in health and disease and how this knowledge can be leveraged to develop treatments for diseases of the TGF-j3 system.
引用
收藏
页码:4007 / 4037
页数:31
相关论文
共 50 条
  • [1] A novel GPI-anchored dominant-negative TGF-j3 receptor II renders T cells unresponsive to TGF-j3 signaling
    Petersen, Sven H.
    Al Badawy, Kays
    Hopkins, Richard
    Vu, Dang L.
    Rahmani, Mehran
    Maia, Sonia M. P.
    Connolly, John E.
    MOLECULAR THERAPY ONCOLYTICS, 2023, 31
  • [2] TGFβ signaling in health and disease
    Rosemary J Akhurst
    Nature Genetics, 2004, 36 : 790 - 792
  • [3] TGFβ signaling in health and disease
    Akhurst, RJ
    NATURE GENETICS, 2004, 36 (08) : 790 - 792
  • [4] Targeting heterogeneous tumor microenvironments in pancreatic cancer mouse models of metastasis by TGF-J3 depletion
    Chen, Sophia Y.
    Kung, Heng-Chung
    Espinoza, Birginia
    Washington, India
    Chen, Kai
    Wang, Jianxin
    Zlomke, Haley
    Loycano, Michael
    Wang, Rulin
    Pickup, Michael
    Burns III, William R.
    Fu, Juan
    Hwang, William L.
    Zheng, Lei
    JCI INSIGHT, 2024, 9 (21)
  • [5] Correction: Corrigendum: TGFβ signaling in health and disease
    R J Akhurst
    Nature Genetics, 2004, 36 (9) : 1024 - 1024
  • [6] TGF-β signaling in health, disease, and therapeutics
    Deng, Ziqin
    Fan, Tao
    Xiao, Chu
    Tian, He
    Zheng, Yujia
    Li, Chunxiang
    He, Jie
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [7] TGFβ signaling pathways in human health and disease
    Chen, Pei-Yu
    Qin, Lingfeng
    Simons, Michael
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [8] TGF-β Signaling in Lung Health and Disease
    Saito, Akira
    Horie, Masafumi
    Nagase, Takahide
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (08)
  • [9] TGF-β signaling in intervertebral disc health and disease
    Chen, S.
    Liu, S.
    Ma, K.
    Zhao, L.
    Lin, H.
    Shao, Z.
    OSTEOARTHRITIS AND CARTILAGE, 2019, 27 (08) : 1109 - 1117
  • [10] TGFβ signaling in health and disease (vol 36, pg 790, 2004)
    Akhurst, RJ
    NATURE GENETICS, 2004, 36 (09) : 1024 - 1024